Yes, that's why I brought that part to the top. It also spiked my interest as well. I think many in the medical community is starting to pay attention to VB-111 and hoping that it makes it through phase 3.
They are already speculating what it can do in combination with other therapies.
News 
Market Data 
Discover 
